1. Home
  2. CLAR vs INDP Comparison

CLAR vs INDP Comparison

Compare CLAR & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clarus Corporation

CLAR

Clarus Corporation

HOLD

Current Price

$3.66

Market Cap

104.9M

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

125.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLAR
INDP
Founded
1957
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.9M
125.2M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
CLAR
INDP
Price
$3.66
$1.14
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$4.08
N/A
AVG Volume (30 Days)
134.6K
800.4K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
3.80%
N/A
EPS Growth
11.68
N/A
EPS
0.04
N/A
Revenue
$228,000.00
N/A
Revenue This Year
$5.27
N/A
Revenue Next Year
$3.99
N/A
P/E Ratio
$93.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.53
$0.92
52 Week High
$4.03
$8.57

Technical Indicators

Market Signals
Indicator
CLAR
INDP
Relative Strength Index (RSI) 53.15 38.68
Support Level $3.52 $0.92
Resistance Level $3.71 $1.58
Average True Range (ATR) 0.11 0.17
MACD -0.02 0.06
Stochastic Oscillator 33.33 30.30

Price Performance

Historical Comparison
CLAR
INDP

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and U.S.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: